Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Next generation fixed dose combination pharmacotherapies for treating HIV.

Caplan MR, Daar ES, Corado KC.

Expert Opin Pharmacother. 2018 Apr;19(6):589-596. doi: 10.1080/14656566.2018.1450866. Epub 2018 Mar 20. Review.

PMID:
29557204
2.

Cytomegalovirus immune reconstitution inflammatory syndrome manifesting as sialadenitis in an HIV-infected patient.

Sheikh V, Caplan M, Wilson EM, Papadi B, Rosenberg AZ, Higgins J, Driscoll B, Filie AC, Sereti I.

AIDS. 2013 Jul 17;27(11):1833-5. doi: 10.1097/QAD.0b013e328362d8b0. No abstract available.

PMID:
23803796
3.

Primary Biliary Cirrhosis Overlapping with Autoimmune Hepatitis in an HIV-Infected Patient on Antiretroviral Therapy.

Caplan M, Trivedi A, McLaughlin M, Hebou A, Kleiner DE, Heller T, Morse CG.

J Interdiscip Histopathol. 2013;1(5):270-273. Epub 2013 Jun 30.

4.

Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.

Yin L, Rodriguez CA, Hou W, Potter O, Caplan MJ, Goodenow MM, Sleasman JW.

J Allergy Clin Immunol. 2008 Jul;122(1):166-72, 172.e1-2. doi: 10.1016/j.jaci.2008.04.029. Epub 2008 Jun 9.

5.

A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

Tang S, Ablan S, Dueck M, Ayala-López W, Soto B, Caplan M, Nagashima K, Hewlett IK, Freed EO, Levin JG.

Virology. 2007 Mar 1;359(1):105-15. Epub 2006 Oct 19.

Supplemental Content

Loading ...
Support Center